Blue Jay Capital Management as of March 31, 2016
Portfolio Holdings for Blue Jay Capital Management
Blue Jay Capital Management holds 16 positions in its portfolio as reported in the March 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Cooper Companies | 9.1 | $14M | 93k | 153.96 | |
| Mead Johnson Nutrition | 9.0 | $14M | 166k | 84.97 | |
| Neurocrine Biosciences (NBIX) | 9.0 | $14M | 357k | 39.55 | |
| Ionis Pharmaceuticals (IONS) | 8.2 | $13M | 319k | 40.50 | |
| Integra LifeSciences Holdings (IART) | 7.8 | $12M | 180k | 67.36 | |
| Abiomed | 7.5 | $12M | 124k | 94.81 | |
| Qiagen | 6.8 | $11M | 475k | 22.34 | |
| St. Jude Medical | 6.7 | $11M | 190k | 55.00 | |
| Agilent Technologies Inc C ommon (A) | 6.4 | $10M | 250k | 39.85 | |
| Shire | 5.0 | $7.8M | 45k | 171.89 | |
| Quest Diagnostics Incorporated (DGX) | 4.2 | $6.6M | 93k | 71.45 | |
| Patterson Companies (PDCO) | 4.2 | $6.6M | 143k | 46.53 | |
| Masimo Corporation (MASI) | 4.1 | $6.4M | 154k | 41.84 | |
| Alexion Pharmaceuticals | 4.0 | $6.3M | 45k | 139.22 | |
| BioMarin Pharmaceutical (BMRN) | 4.0 | $6.2M | 75k | 82.48 | |
| Incyte Corporation (INCY) | 3.9 | $6.2M | 85k | 72.47 |
